Vivos Therapeutics (VVOS) Return on Sales (2020 - 2026)

Vivos Therapeutics (VVOS) has 7 years of Return on Sales data on file, last reported at 0.02% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.02%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Sales rose to 0.02% in Q1 2026 per VVOS's latest filing, from 0.02% in the prior quarter.
• Over five years, Return on Sales peaked at 0.03% in Q4 2023 and troughed at 0.02% in Q4 2025.
• A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2023 and 2024: Return on Sales grew 4 bps in 2023, then decreased 4 bps in 2024.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then surged by 287 bps to 0.03% in 2023, then plunged by 127 bps to 0.01% in 2024, then tumbled by 133 bps to 0.02% in 2025, then grew by 17 bps to 0.02% in 2026.
• Business Quant data shows VVOS's Return on Sales at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.